Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
UCSF Benioff Children's Hospitals, San Francisco, California Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts